助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[15]条 当前为第1条到15条
 

相关语句
恶性血液病
    Measurement of soluble Fas in patients with hematological malignancy
    恶性血液病患者血清中可溶性Fas水平的测定
    Clinical study of umbilical cord blood transplantation in patients with hematological malignancy
    脐血移植治疗恶性血液病的临床研究
    Expression of survivin mRNA in HHT-induced cell apoptosis of hematological malignancy cell lines
    survivin mRNA表达水平与高三尖杉酯碱诱导恶性血液病细胞凋亡的相关性研究
    We measured serum levels of soluble Fas(sFas) in 68 patients with hematological malignancy by using sandwich ELISA and detected bone marrow mononuclear cell membrane Fas(mFas) positive cells in 46 patients with acute leukemias by immunohistochemical technic.
    用ELISA法测定68例恶性血液病患者血清可溶性48kD跨膜糖蛋白(sFas)水平,用免疫组织化学SABC法检测其中46例急性白血病患者骨髓单个核细胞膜Fas(mFas)阳性表达细胞数。
    Results: The expression of p170 were 45.0% in the hematological malignancy patients with untreated,the expression of peripheral blood p170 were 30.7% in the patients with AL untreated.
    结果 :初治恶性血液病患者 p170阳性表达率45 .0 % ,初治急性白血病外周血 p170高表达占 30 .7%。
    METHODS Sixty patients (M 34,F 26),age (42±15)a,with leucopenia after the chemotherapy for hematological malignancy were divided at random into 2 groups,treatment group and control group.
    方法 选择恶性血液病化疗后WBC减少期患者6 0例(男34例,女2 6例) ,年龄(42±15 )a,随机分为2组。
    Cefoperazone-sulbactam for treatment of bacterial infections in patients with leucopenia after the chemotherapy for hematological malignancy
    头孢哌酮-舒巴坦对恶性血液病化疗后白细胞减少期并发感染的疗效
    A New Method for 5,10-Methylenetetrahydrofolate Reductase Single Nucleotide Polymorphisms Genotyping Used to Study Susceptibility of Hematological Malignancy
    新型亚甲基四氢叶酸还原酶单核苷酸多态性研究方法检测恶性血液病易感性
    Twelve cases of hematological malignancy were treated with different doses of the total body irradiation (TBI) twice a day plus the high dose of cyclophosphamide (CY) as condition regimen for autologous or allogeneic bone marrow transplantation or blood stem cell transplantation.
    一日两次不等剂量全身放疗(TBI)加环磷酰胺(CY)预处理,自体或异基因骨髓移植(BMT)或外周血造血干细胞移植(PBST)治疗12例恶性血液病
    Method:11 patients with hematological malignancy were transplanted with related umbilical cord blood.
    方法 :用CBT治疗恶性血液病 11例。
    Conclusions AHBI provides a feasible approach for hematological malignancy patients.
    结论 AHBI可作为恶性血液病的一种治疗手段。
    AIM To observe the effect of cefoperazone-sulbactam for treatment of bacterial infections in leucopenia patients with hematological malignancy after chemotherapy.
    目的 观察头孢哌酮-舒巴坦对恶性血液病化疗后WBC减少期并发细菌感染的疗效。
    CONCLUSION Cefoperazone-sulbactam is an effective drug in the treatment of bacterial infections in patients with leucopenia after the chemotherapy for hematological malignancy.
    结论 头孢哌酮-舒巴坦是治疗恶性血液病化疗后WBC减少期并发细菌感染的有效药物。
    The aim of this study was to set up a new method for 5,10-Methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms (SNP) genotyping, and to investigate the hereditary susceptibility of hematological malignancy.
    本研究探讨一种新型亚甲基四氢叶酸还原酶(MTHFR)单核苷酸多态性(SNP)检测方法,并用其检测恶性血液病遗传易感性。
    Conclusion: Itraconazole injection is effective and safe in treatment of invasive fungal infections in patients with hematological malignancy
    结论伊曲康唑注射液对恶性血液病合并侵袭性真菌感染疗效显著,对存在危险因素的患者早期诊断,积极治疗,可取得良好效果。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社